Drug Trial Radar · NCT00003421
Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease
Last checked: Nov 19, 2026Latest source record: Dec 4, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
800
Planned (sponsor's estimate)
Start
Jun 1998
Primary completion
Not stated
Study completion Nov 2005
Sponsor
- Lead sponsor
- Medical Research CouncilGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Mar 12, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Primary purpose
- Treatment
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which chemotherapy regimen is more effective for advanced Hodgkin's disease. PURPOSE: Randomized phase III trial to compare different combination chemotherapy regimens in treating patients with advanced Hodgkin's disease.
Conditions
- Lymphoma
Interventions
bleomycin sulfateBiological
ABVD regimenDrug
chlorambucilDrug
dacarbazineDrug
doxorubicin hydrochlorideDrug
etoposideDrug
prednisoloneDrug
procarbazine hydrochlorideDrug
vinblastine sulfateDrug
vincristine sulfateDrug
radiation therapyRadiation
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
St. James's Hospital
Leeds, England, United Kingdom
Weston Park Hospital
Sheffield, England, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.